Archive: 11/04/2016
A novel mechanism of crizotinib resistance in a ROS1+ NSCLC patient
Molecular analysis of a tumor biopsy from a proto-oncogene 1 receptor tyrosine kinase positive (ROS1+) patient with acquired crizotinib resistance revealed a novel mutation in the v-kit Hardy Zuckerman 4 feline sarcoma viral ...
Apr 11, 2016
Vascular Medicine editorial on PAD recommendations to MEDCAC panel
The Society for Vascular Medicine (SVM) is a part of a coalition of five leading nonprofit professional societies that has made recommendations for the treatment of peripheral artery disease (PAD) to the Centers for Medicare ...
Apr 11, 2016